India’s pharmaceutical exports are anticipated to hit $350 billion by 2047, representing a potential increase of 10 to 15 times from current figures.
As a prominent global supplier of generic medications, the country is expected to enhance its position by advancing into speciality generics, biosimilars, and cutting-edge pharmaceutical innovations.
A recent report from Bain & Company, in partnership with Indian pharmaceutical organizations, indicates that while India is currently positioned 11th in terms of pharmaceutical export value, it has the potential to rise to one of the top five countries by 2047. The report forecasts that India’s pharmaceutical exports will increase from around $27 billion in 2023 to $65 billion by 2030, ultimately aiming for an ambitious target of $350 billion by the centenary of India’s independence.
